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The development of infl  ammation depends not 
only on the immune response but also on an 
appropriate tissue response. Resident tissue cells 
play an essential role in infl  ammation by recruit-
ing immune cells (1). The expression of adhe-
sion molecules and the increase in permeability 
are two important changes that endothelial cells 
undergo to facilitate infl  ammation. Among many 
adhesion molecules, vascular cell adhesion mol-
ecule (VCAM)–1 plays a nonredun  dant role in 
Th2-type infl  ammation because of its selective 
recruitment of eosinophils and T cells (2). Endo-
thelial permeability requires disassembly of inter-
cellular junctions and cell shrinkage (3). These 
two processes are tightly linked to the actin cyto-
skeleton (4). The p38 mitogen-  activated protein 
kinase (MAPK) is known to regulate many 
functions of endothelial cells (5–7). The p38 
kinase activates several downstream eff  ectors, 
and one of them is MAPK-activated kinase 2 
(MK2; also known as MAPKAP-K2), which is 
a serine/threonine kinase (8). MK2 KO mice are 
resistant to endotoxic shock (9), which is a con-
dition where endothelial cells play a promi-
nent role. We hypothesize that MK2 regu  lates 
endothelial activities that are essential for devel-
opment of infl  ammation.
RESULTS
MK2 KO mice are unable to increase 
vascular permeability in response to an 
allergen challenge
We studied the role of MK2 in vascular perme-
ability and infl  ammation in a murine model of 
asthma using MK2 KO animals. MK2 KO and 
littermate (129/C57BL/ 6) control mice were 
immunized with and exposed to OVA, as pre-
viously described (10). We examined pulmonary 
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vascular permeability for Evans blue dye after an allergen chal-
lenge (11). Vascular permeability was signifi  cantly decreased 
(P < 0.05 for each time point after challenge) in MK2 KO 
mice compared with immunized and challenged control mice 
(referred to as control mice hereafter; Fig. 1 A) and was iden-
tical to that in nonimmunized mice. Thus, MK2 KO mice 
are unable to increase vascular permeability in response to 
the allergen.
MK2 KO mice do not increase actin polymerization 
and disrupt endothelial adherens junctions in response 
to an allergen challenge
Formation of intercellular gaps is essential for increased per-
meability. It requires endothelial cell shrinkage through actin 
polymerization (1, 4). Pulmonary vascular endothelial cells 
from control mice showed signifi  cantly (P = 0.012) in-
creased actin polymerization (Fig. 1 B and Fig. S1, available at 
Figure 1.  Pulmonary endothelium in MK2 KO mice. (A) MK2 knock-
out mice (KO, black bar) and their littermate controls (C, open bar) were 
immunized and challenged with OVA. Nonimmunized (alum-injected), 
saline-challenged MK2 knockout (KO NI, dark gray bar), and littermate 
control (C NI, light gray bar) mice were also studied. Pulmonary vascular 
permeability was assessed. 24, 48, 72, or 96 h after OVA challenge, mice 
were i.v. injected with Evans blue dye. Next, a blood sample was taken and 
lungs were removed. The histogram shows the mean ratio between the 
amount of the dye extracted from 100 mg of the lung tissue and the 
amount of the dye extracted from 100 μl of plasma (lung/plasma ratio of 
Evans Blue dye = permeability index). Error bars show the SEM (n = 5 
mice per group). (B) Lung sections from immunized mice obtained 24, 48, 
72, and 96 h after OVA challenge or from nonimmunized mice were 
stained with rhodamine-labeled phalloidin to detect polymerized actin 
(red). The pictures show staining of pulmonary endothelium from immu-
nized mice 24 h after OVA challenge and from nonimmunized mice. 
The histogram to the right shows mean pixel intensity of endothelial cell 
staining (blood vessels with a lumen perimeter of 0.1–1.5 mm; n = 3 
mice per group). Intensity is expressed in arbitrary units (AU). (C) Lung 
sections from mice treated as in A were immunostained for β-catenin 
(green). Lung sections from control nonimmunized (C NI) mice were also 
stained with isotype control IgG. The graph shows mean immunostained 
area per mm of blood vessel with a lumen perimeter of 0.1–1.5 mm (n = 3 
mice per group). Ab, antibody. (D) Lung sections from immunized and 
challenged mice (as in A) were stained with anti–VCAM-1 (green) or anti–
ICAM-1 (staining not depicted) antibodies. Histograms show mean immuno-
stained area per millimeter of blood vessel with a lumen perimeter of 
0.1–1.5 mm (n = 3 mice per group). NS, statistically not signifi  cant. Bars: 
(B and C) 10 μm; (D) 20 μm.JEM VOL. 204, July 9, 2007  1639
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compared with nonimmunized animals. In contrast, MK2 KO 
mice showed a twofold reduction (P = 0.006) in endothelial 
actin polymerization. In agreement with our results, a recent 
paper demonstrated reduced actin polymerization in endothe-
lial cells overexpressing a dominant-negative MK2 (12).
β-catenin is an essential component of adherens junc-
tions, and it normally stains the cellular border (1). β-catenin 
knockout endothelial cells have increased permeability (13). 
An allergen challenge of control mice caused disappearance 
of junctional β-catenin, indicating a disruption of adherens 
junction (Fig. 1 C). In contrast, MK2 KO mice showed an 
overall increase in β-catenin staining along the cell border.
Impaired VCAM-1 expression, infl  ammatory cell 
accumulation, and Th2 cytokine production in the lung 
from MK2 KO mice
Lung endothelium from MK2 KO mice showed a 10-fold re-
duction (P = 7.5 × 10−4) in VCAM-1 expression compared 
with control mice (Fig. 1 D). Intercellular adhesion molecule 
(ICAM)–1 expression was similar in both groups. Control 
mice demonstrated pronounced peribronchial infl  ammation 
after the allergen challenge (Fig. 2 A). The mean peribronchial 
infl  ammatory area was reduced by 7.5-fold in MK2 KO mice 
(P = 0.0018). Furthermore, MK2 KO mice demonstrated a 
signifi  cant (P = 9.4 × 10−5) reduction in the total number of 
bronchoalveolar lavage (BAL) cells (Fig. 2 B). The percentage 
of eosinophils in the BAL fl  uid from control mice was 37 ± 
5%, but only 9 ± 3% in MK2 KO mice (P = 0.04).
The profound reduction in the eosinophil number in the 
lung from MK2 KO mice suggested an impaired Th2 immu-
nity. In agreement, Th2 cytokine mRNA was expressed at a 
reduced level in the lung from MK2 KO mice, as follows: 
IL-4 (fourfold reduction, P = 0.016), IL-5 (3.7-fold reduc-
tion, P = 0.042), IL-10 (twofold reduction, P = 0.042), and 
IL-13 (twofold reduction, P = 0.029; Fig. 2 C).
Mucus production, extracellular matrix (ECM) protein 
deposition, airway smooth muscle hypertrophy, and airway 
hyperresponsiveness (AHR) in MK2 KO mice
Thickening of the smooth muscle layer, mucus, and ECM 
overproduction are important consequences of airway allergic 
infl  ammation. MK2 KO mice showed a profound reduction 
in all of the aforementioned aspects of tissue remodeling (Fig. 
S2, A–C, available at http://www.jem.org/cgi/content/full/
jem.20062621/DC1). The basal function of lung-resident cells 
is regulated by tissue-derived factors, such as epidermal growth 
factor (EGF) (14, 15). The staining with an anti–phospho-EGF 
receptor antibody (Tyr1173) was equally intensive in MK2 KO 
and control mice (Fig. S2 D). AHR was assessed by measuring 
total lung resistance to increasing doses of methacholine (Fig. 
2 D). OVA challenge of control mice resulted in an increase 
in lung resistance starting at the lowest methacholine dose and 
reaching a 9.4-fold increase over baseline at the highest dose. The 
airway resistance of MK2 KO mice was signifi  cantly lower at 
each methacholine dose compared with control mice (Student’s 
t test, P < 0.04 for each methacholine dose; repeated measures 
ANOVA, P = 0.0004 for the entire dose–response curve).
Figure 2.  Local (airway) immune response in MK2 KO mice. (A) Lung 
sections from immunized and challenged mice (as in Fig. 1 A) were stained 
with HE. Bars, 100 μm. Histogram shows mean area of infl  ammation per 
millimeter of BM of mid-size bronchi (BM perimeter range 0.4–2.0 mm; 
n = 6 mice per group). (B) The left histogram presents the mean 
number of BAL cells. The right histogram shows the cellular composition 
of the BAL fl  uid. The mean number of macrophages (M), eosinophils (E), 
neutrophils (N), and lymphocytes (L) is displayed as a percentage of the 
total cell number (n = 8 mice for C group and 10 mice for KO group). 
(C) RNA was extracted from lungs obtained from mice treated as in Fig. 1 A. 
Cytokine and β-actin mRNA was quantifi  ed by real-time RT-PCR. Histo-
grams show mean number of cytokine mRNA copies per 106 copies of 
β actin mRNA (n = 3 mice per group). (D) Immunized and challenged con-
trol and KO (as in Fig. 1 A), as well as nonimmunized control (C NI) mice 
were exposed fi  rst to saline aerosol, and then to increasing concentrations 
of methacholine, and total lung resistance was measured. Baseline resis-
tance was obtained before any aerosol administration (n = 5 mice per 
C and KO group; n = 3 mice per C NI group). Error bars represent the SEM.1640  MK2, NF-κB, AND AIRWAY INFLAMMATION | Gorska et al.
Figure 3.  Systemic immune response in MK2 KO mice. (A) Cytokine 
concentration in the liver lysate from immunized mice (KO and C) and 
nonimmunized control mice (C NI, gray bar) was measured by ELISA (each 
experiment in duplicates, n = 3 mice per group). Values were adjusted for 
the protein concentration in the lysate. (B) Splenocytes from mice as in 
Fig. 1 A were stimulated with 10 or 50 μg/ml OVA (OVA 10 or OVA 50) or 
PHA at 5 μg/ml. [3H]thymidine incorporation was measured (experiment 
in triplicates; n = 4 mice per C group; n = 6 mice per KO group; n = 3 
mice per C NI group). CPM, counts per minute. (C) Mice were treated as 
in Fig. 1 A. OVA-specifi  c IgE in the serum was measured by ELISA (each 
experiment in duplicates; n = 3 mice per C or C NI group; n = 5 mice 
per KO group). ND, not detected. (D) CD4 T cells were isolated from the spleen 
of immunized mice (as in Fig. 1 A) and assayed for chemotaxis toward 
MCP-1. The histogram shows the percentage of migrated CD4 T cells 
(experiment in duplicates; n = 3 mice per group). (E) Mice were injected i.v. 
with OVA peptide-activated OT-2 T cells and exposed to OVA or saline 
aerosol. Airway infl  ammation was measured as in Fig. 2 A. C saline, saline-
exposed control mice; C OVA or KO OVA, OVA-exposed control or MK2 KO 
mice, respectively (n = 3 mice per group). Bars, 100 μm. (F) Lysates from 
organs obtained from nonimmunized wild-type (C57BL/6) mice and from 
human (HUVEC) and mouse (SVEC) endothelial cells were Western blotted 
with an anti-MK2 antibody, followed by sequential reprobing with anti-
HSP27 and anti–β-tubulin antibodies. hMK2, human MK2; mMK2, murine 
MK2; hHSP27, human HSP27; mHSP27, murine HSP27. Error bars repre-
sent the SEM.JEM VOL. 204, July 9, 2007  1641
ARTICLE
Systemic T helper immunity in MK2 KO Mice
We wondered if MK2 KO mice had a systemic defect in 
cytokine production. We measured T helper cytokines in a 
diff  erent organ, i.e., liver by ELISA. IL-4, IL-5, and IFNγ levels 
in the liver homogenates from MK2 KO and control mice 
were similar and 3.2–14.3-fold higher than levels in the non-
immunized group (Fig. 3 A). OVA-stimulated proliferation 
of splenocytes from MK2 KO mice was slightly higher than 
that from control mice (Fig. 3 B). PHA-stimulated prolifera-
tion was similar in both groups. The OVA-specifi  c IgE levels 
in the serum from MK2 KO and control mice were similar 
(Fig. 3 C). Monocyte chemoattractant protein (MCP)–1-
  directed, as well as spontaneous, migration of MK2 KO and 
control CD4 T cells were similar (Fig. 3 D). Adoptively 
transferred, activated, OVA-specifi  c, MK2-suffi   cient OT-2 
T cells were unable to reconstitute airway infl  ammation in 
MK2 KO mice in response to OVA aerosol challenge (Fig. 
3 E) (16). They induced considerable airway infl  ammation 
in control mice. Finally, the eosinophil counts in the peri-
pheral blood from control and MK2 KO mice were equal 
( 2%). Thus, lack of allergic infl  ammation in MK2 KO 
mice cannot be attributed to the impairment of the systemic 
T helper response.
The expression of MK2 protein and its substrate HSP27 
was considerably lower or minimally present, respectively, in 
splenocytes compared with endothelial cells or lung, and the 
expression was almost undetectable in the liver (Fig. 3 F). 
This low-level expression is the likely explanation for the 
relatively unperturbed function of lymphocytes from the 
blood, spleen, and liver from MK2 KO mice.
Production of TNF𝗂 and chemokine in MK2 KO mice
TNFα is a master regulator of infl  ammation, and its synthesis 
is regulated by the p38 pathway (17, 18). TNFα production 
was shown to be decreased in LPS-stimulated MK2 KO 
spleen cells in a previous study (9). The TNFα mRNA level 
in the lung and TNFα protein level in the liver from immu-
nized MK2 KO mice were similar to those in control mice 
(Fig. 4 A). The discrepancy between the abovementioned 
study and our data might be the result of the diff  erences 
in the stimulus and model used. We examined representa-
tive chemokine expression in the lung (Fig. 4 B). The ex-
pression of MCP-1, MCP-3, and eotaxin mRNA in KO mice 
was reduced by 3.1- (P = 6.3 × 10−4), 3.8- (P = 0.016), 
and 1.9-fold (P = 0.034), respectively. We believe that the 
  reduction in infl  ammatory cells and cytokines in the MK2 
KO lung is the result of aberrant endothelial function, defec-
tive chemokine expression, and faulty cell recruitment into 
the airways.
Reduced allergic infl  ammation after administration 
of a neutralizing anti–VCAM-1 antibody
We wondered if a perturbation in endothelial function 
in wild-type mice could reproduce the MK2 phenotype. 
Figure 4.  Other mechanisms of leukocyte recruitment to the 
lung of MK2 KO mice. (A, left) TNFα and β-actin mRNA in the lung 
was quan  tifi  ed by real-time RT-PCR, as in Fig. 2 C. The histogram shows 
the mean number of TNFα mRNA copies per 106 copies of β-actin 
mRNA (n = 3 mice per group). (right) The concentration of TNFα in the 
liver lysate was measured by ELISA as in Fig. 3 A (each experiment in 
duplicates, n = 6 mice for the control group, 8 mice for the KO group, 
and 3 mice for the C NI group). (B) MCP-1, MCP-3, eotaxin, and β-actin 
mRNA in the lung was quantified by real-time RT-PCR as in Fig. 2 C. 
The histograms show mean copies of MCP-1 (left), MCP-3 (middle), and 
eotaxin (right) mRNA per 106 copies of β actin mRNA (n = 3 mice per 
group). (C) Wild-type mice (C57BL/6) were immunized with OVA as in 
Fig. 1 A and pretreated i.v. with 10 mg/kg neutralizing anti–VCAM-1 
antibody or isotype control antibody (Ab), followed by OVA challenge. 
Lung sections were stained with HE, and the airway infl  ammation was 
measured as in Fig. 2 A (right, n = 2 mice per group). Bars, 200 μm. 
Error bars represent the SEM.1642  MK2, NF-κB, AND AIRWAY INFLAMMATION | Gorska et al.
OVA-immunized wild-type mice were pretreated with a neu-
tralizing anti–VCAM-1 antibody before an inhalation challenge. 
We observed a 5.2-fold (P = 2.3 × 10−4) reduction in peri-
bronchial infl  ammation in anti-VCAM-1–pretreated mice com-
pared with mice pretreated with the control IgG (Fig. 4 C).
Reduced phosphorylation of HSP27 and nuclear 
translocation of p65 NF-𝗋B in MK2 KO mice
NF-κB is an important transcriptional regulator of VCAM- 1 
gene (19, 20). Among the MK2-regulated proteins, HSP27 
and Akt have been linked to the activation of NF-κB (21–23). 
Figure 5.  Nuclear targeting of NF-𝗋B in the lung of MK2 KO 
mice. (A, left) Lung sections from immunized and challenged mice 
(as in Fig. 1 A) were stained with an anti–phospho-HSP27 (Ser15) 
antibody (green). The histogram shows mean phospho-HSP27–positive 
(pHSP27+) area per millimeter of blood vessel perimeter (lumen perim-
eter range, 0.1–1.5 mm; n = 3 mice per group). (A, right) Lung lysates 
from immunized and challenged mice (as in Fig. 1 A) were Western 
blotted with an anti–phospho-HSP27 (Ser15) antibody. The membrane 
was reprobed with an anti-HSP27 and, next, with an anti–β-tubulin 
antibody. (B) Lung sections from immunized and challenged mice 
(as in Fig. 1 A) were stained with DAPI (staining nucleus in blue) and 
an antibody against the p65 subunit of NF-κB (green) or phospho-CREB 
(Ser133, staining not depicted). Arrows indicate p65 NF-κB–positive 
nuclei. Histograms show mean percentage of endothelial and epithelial 
cells showing nuclear p65 NF-κB (left; n = 3 mice per group) or pCREB 
(right; n = 3 mice per group). (C, left) Mice were immunized and chal-
lenged with OVA as in Fig. 1 A. (C, right) Naive nonimmunized mice were 
intranasally exposed to LPS (as a positive control for NF-κB activation) 
or saline. The DNA-binding capacity of p65 in lung nuclear extracts was 
measured using the TransAM NF-κB p65 ELISA kit (Active Motif; n = 3). 
(right) Black (KO LPS) or dark gray (KO saline) bars, MK2 knockout 
administered with LPS or saline, respectively; open (C LPS) or light gray 
(C saline) bars, littermate control mice administered with LPS or saline, 
respectively. Bars: (A) 50 μm; (B, top) 10 μm; (B, bottom) 5 μm. Error 
bars represent the SEM.JEM VOL. 204, July 9, 2007  1643
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HSP27 has actin-capping activity, which is inhibited by its 
phosphorylation (24). There was no diff  erence in the lung 
staining pattern of phosphorylated Akt (Ser438, which is 
an MK2 phosphorylation site) between KO and control 
mice (unpublished data). In contrast, HSP27 phosphorylation 
(Ser15, which is an MK2-specifi  c HSP27 phosphorylation 
site [25]) was reduced by 3.6-fold (P = 8.4 × 10−4) in MK2 
KO mice (Fig. 5 A). The reduction was most prominent in 
pulmonary vascular endothelial cells. Next, lung tissue was 
examined for nuclear p65 NF-κB and, as a control, nuclear 
phospho–cAMP response element binding protein (CREB; 
Ser133) (Fig. 5 B). MK2 KO mice showed reduced nu-
clear p65, but not phospho-CREB, in most cells in the lung. 
We quantifi  ed nuclear p65 in endothelial and bronchial 
epithelial cells because the expression of NF-κB–  dependent 
molecules (VCAM-1 and chemokines, respectively) was de-
creased in these cells (20). The number of endothelial and 
bronchial epithelial cells with nuclear p65 was reduced by 
Figure 6.  Nuclear targeting of NF-𝗋B after inhibition of MK2 or 
HSP27 in endothelial cells. (A) HUVECs were treated with Lipofectamine 
2000 alone (−), Lipofectamine 2000 plus control, nontargeting siRNA (C), 
or siRNA against MK2 (M) or HSP27 (H). Cell lysates were Western blotted 
with anti-MK2 (left) or anti-HSP27 (right) antibodies (Ab). The membrane 
was reprobed with an anti–β-tubulin antibody. (B and D) HUVECs trans-
fected as in A were stimulated with TNFα for 15, 30, 90, 180, or 300 min, 
or left unstimulated. Next, cells were immunostained for p65. siNT-
transfected cells were also stained with isotype control IgG. (B) The images 
show p65 staining of cells stimulated with TNFα for 5 h. Only two HSP27-
defi  cient cells are shown because of the increased size (Fig. 10 A). Bar, 10 μm. 
The integrated intensity of cytoplasmic and nuclear p65 staining was 
measured. (D) The graph shows nuclear to cytoplasmic (N:C) ratio of p65 
staining intensity at each time point of TNFα stimulation (n = 10–20 
representative cells from 3 separate experiments). The dashed line repre-
sents the baseline (no TNFα) N:C ratio. (C and F) HUVECs transfected with 
the empty vector (Empty) or vector containing an HA-tagged wild-type 
HSP27 cDNA (HSP27 WT) or HA-tagged mutant HSP27 (Ser15,78,82Ala = 
S3A) were stimulated as in B, immunostained for the HA-tag (red) and 
p65 (green), and treated with DAPI (staining nuclei in blue). Images of 
cells at 5 h of stimulation are shown in C. Bars, 25 μm. (F) The N:C ratio 
was measured as in D. Only HA-positive cells (HSP27 WT and HSP27 S3A) 
were assessed. The dashed line represents the baseline (no TNFα) N:C ratio 
(n = 10–20 representative cells from 3 separate experiments). (E) HUVECs 
transfected with siRNA for MK2 (siMK2, fi  lled bars) or nontargeting siRNA 
(siNT, open bars) were stimulated with TNFα for 30 or 300 min, or left 
unstimulated (−). The DNA-binding capacity of p65 in nuclear extracts 
was assessed as in Fig. 5 C (n = 3). Error bars represent the SEM.1644  MK2, NF-κB, AND AIRWAY INFLAMMATION | Gorska et al.
3.7- (P = 3.7 × 10−5) and 3.9-fold (P = 3.2 × 10−6), respec-
tively. We measured the DNA-binding capacity of NF-κB 
in nuclear extracts from the lung of MK2 KO and control 
mice (Fig. 5 C). We used an ELISA-based TransAM NF-κB 
Activation kit (26–28). The   advantage of this ELISA-based 
approach over the traditional EMSA is that the former pro-
vides quantitative results. To induce NF-κB activation in the 
lung, mice were intranasally challenged with OVA or LPS 
(positive control). Both OVA and LPS treatment substantially 
increased the DNA-binding capacity of p65 in the lung of 
control mice. The DNA-binding capacity of p65 in OVA- 
and LPS-treated MK2 KO mice was reduced by 6.5- and 
5-fold, respectively, compared with control mice. We checked 
the specifi  city of the assay. Soluble competitor oligonucleo-
tides containing the wild-type or mutated NF-κB consensus-
binding site were added in excess to the nuclear extract from 
LPS-treated control lung. The wild-type oligo prevented NF-
κB binding to the immobilized probe (OD 450 nm = 0.044 ± 
0.014). The mutated oligo had no eff  ect (OD 450 nm = 
0.568 ± 0.131).
Impaired nuclear retention of p65 in MK2- and HSP27-
defi  cient endothelial cells
To determine their role in NF-κB regulation, we performed 
MK2 and HSP27 knockdown experiments (Fig. 6 A) in human 
umbilical vein endothelial cells (HUVECs). MK2, HSP27, or 
nontargeting siRNA-transfected HUVECs were stimulated 
with TNFα and then immunostained for p65 (Fig. 6 B). At 
early time points (15 and 30 min), the nuclear/cytoplasmic 
ratio of p65 was similar in all study groups (Fig. 6 D). At later 
time points, cells transfected with MK2 or HSP27 siRNA 
demonstrated an accelerated loss of p65 from the nucleus. 
Therefore, MK2 or HSP27-defi  cient cells have the ability to 
translocate p65 to the nucleus at a normal rate, but are un-
able to sustain it in this location. Interestingly, we noticed 
that the size of HSP27-defi  cient HUVECs was considerably 
increased. We speculate that it is caused by an abnormal cyto-
skeleton because HSP27 is a known regulator of actin poly-
merization. We also measured NF-κB activation in nuclear 
extracts from transfected HUVECs (Fig. 6 E). At an early 
time point (30 min) of TNFα stimulation, the DNA-binding 
capacity of p65 was similar in siNT and siMK2-transfected 
cells. However, at a late time point (5 h), siMK2-transfected 
cells demonstrated a 4.7-fold reduction in the DNA-binding 
capacity of p65.
Impaired nuclear retention of p65 in cells expressing 
a nonphosphorylatable mutant of HSP27
MK2 phosphorylates HSP27 at serine 15, 78, and 82 (29). 
We asked if this phosphorylation was necessary to maintain 
p65 in the nucleus after TNFα stimulation. HUVECs were 
transfected with a nonphosphorylatable mutant of HSP27 
(Ser15,78,82Ala), wild-type HSP27, or empty vector (Fig. 6 C). 
The kinetics of p65 nuclear localization in mutant HSP27-
expressing cells resembled that in HSP27-defi  cient cells (Fig. 
6 F), suggesting a necessary role for HSP27 phosphorylation.
Reversal of impaired nuclear retention of p65 
by leptomycin B
We examined the mechanism of shortened nuclear presence 
of NF-κB. MK2- or HSP27-defi  cient cells and control cells 
were treated with the CRM1 inhibitor leptomycin B before 
TNFα stimulation. CRM1, which is an exportin-type nuclear 
chaperone, exports NF-κB back to the cytosol (30). Pretreat-
ment with leptomycin B caused remarkable nuclear accu-
mulation of p65 in both MK2- and HSP27-defi  cient cells 
(Fig. 7 A). The results indicate that accelerated nuclear export 
is the primary cause of reduced nuclear p65.
Increased 𝖰𝗋B𝗂 in cells transfected with MK2 
or HSP27 siRNA
NF-κB is exported from the nucleus with the help of newly 
synthesized ΙκBα (31, 32). This occurs because ΙκBα is one of 
the fi  rst target genes of NF-κB. The IκBα level in unstimu-
lated MK2- or HSP27-defi  cient cells was comparable to that 
in control cells (Fig. 7 B). 15 min of TNFα stimulation re-
sulted in the disappearance of IκBα protein in all 3 groups. 
Lack of IκBα at this time point correlated well with initially 
unperturbed nuclear translocation of p65. However, starting 
at 30 min, a substantial increase in IκBα was seen in MK2- 
and HSP27-defi  cient cells compared with control cells. This 
increase reached the peak at 90 min and slowly decreased, but 
never returned to the control cell level over the next 3.5 h. 
Immunostaining of lung sections demonstrated a fourfold in-
crease in IκBα protein (P = 6.7 × 10−5) in endothelial cells 
(as well as other lung cells) from immunized and challenged 
MK2 KO mice (Fig. 7 C). The expression of IκBα protein in 
lungs from nonimmunized control and KO mice was equal 
(unpublished data).
Increased I𝗋B𝗂 mRNA in MK2-defi  cient cells 
upon TNF𝗂 stimulation
We studied the mechanism of increased expression of IκBα. 
MK2 and HSP27 were reported to impact the degradation 
of IκBα protein through the regulation of the IKK complex 
and proteasome (22, 23). Because the degradation of pre-
existing IκBα is intact in HSP27- and MK2-defi  cient cells, 
we studied the degradation of newly synthesized IκBα. We 
examined how quickly IκBα disappeared when protein 
  synthesis was blocked by the addition of cycloheximide 
80 min after TNFα-stimulation (Fig. 7 D). The rate of 
IκBα degradation in MK2- or HSP27-defi  cient cells was 
similar to that in control cells. Degradation of IκBα protein 
in cycloheximide-treated MK2- and HSP27-defi  cient cells 
was accompanied by the marked increase of nuclear NF-
κB (Fig. 7 A). The activation of IKK was intact in MK2-
defi  cient cells (Fig. 7 E).
Because we did not see decreased degradation of IκBα 
protein, we examined IκBα mRNA levels (Fig. 7 F). The 
rate at which IκBα mRNA increased upon addition of  TNFα 
was much faster in MK2- or HSP27-defi  cient cells compared 
with control cells. For all three groups, IκBα mRNA peaked 
at 90 min. The peak of IκBα mRNA level  (Fig. 7 E) was JEM VOL. 204, July 9, 2007  1645
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slightly delayed compared with the peak of nuclear p65 (Fig. 
6 D). At 90 min, the IκBα mRNA concentration was 2 times 
higher in MK2-defi  cient cells and 1.6 times higher in HSP27-
defi  cient cells than in control cells. After 90 min, the level of 
IκBα mRNA rapidly decreased in MK2- or HSP27-defi  cient 
cells, but persisted at nearly the same level in control cells. 
This rapid drop in IκBα mRNA in MK2- or HSP27-defi  cient 
cells correlated well with the disappearance of p65 from the 
Figure 7.  The regulation of I𝗋B𝗂 level by MK2 and HSP27. (A) After 
siRNA transfection (as in Fig. 6 A), HUVECs were preincubated with lepto-
mycin B (LMB), cycloheximide (CHX), or vehicle (−), and then stimulated 
with TNFα for 3 h. Cells were then immunostained for p65. The p65 
N:C ratio at 3 h of stimulation was measured as in Fig. 6 D (n = 10–20 
representative cells from 3 separate experiments). (B) After siRNA trans-
fection (as in Fig. 6 A), HUVECs were stimulated with TNFα for 15, 30, 90, 
180, or 300 min, or they were left unstimulated (–). Cell lysates were 
Western blotted with anti-IκBα, followed by membrane reprobing with 
anti–β-tubulin antibody. C, control siNT; H, siHSP27; M, siMK2. (C) Lung 
sections from immunized and challenged mice (as in Fig. 1 A) were immuno-
stained for IκBα (green) and treated with DAPI (nuclei pseudocolored 
in red). The two images to the left show IκBα staining in blood vessels. 
Bars, 10 μm. The two images to the right show IκBα and DAPI staining in 
the bronchial epithelium. Bars, 5 μm. The histogram shows mean pixel 
intensity (AU) of endothelial staining. Blood vessels of 0.1–1.5 mm lumen 
perimeter were examined (n = 3 mice per group). (D) HUVECs transfected 
as in Fig. 6 A were stimulated with TNFα. At 80 min of stimulation, cyclo-
heximide (CHX) was added and cells were incubated for an additional 
15, 30, or 60 min, and lysed. Control samples were lysed at 80 min of TNFα 
stimulation without CHX addition (−). Lysates were Western blotted with 
an anti-IκBα antibody. Membranes were reprobed with an anti-β-tubulin 
antibody. The IκBα band intensity was measured using Metamorph soft-
ware and expressed in AUs. (E) After siRNA transfection (as in Fig. 6 A), 
HUVECs were stimulated with TNFα for 10 or 30 min or left unstimulated 
(−). Cell lysates were Western blotted with anti–phospho-IKKα/β (Ser 
176/180 in IKKα and Ser 177/181 in IKKβ). The membrane was reprobed 
with anti-IKKβ antibody. C, control siNT; M, siMK2. (F) Cells transfected as 
in Fig. 6 A were stimulated as in Fig. 7 B. Real-time RT-PCR for IκBα and 
β-actin mRNA was performed. The quantity of IκBα mRNA was normal-
ized to the quantity of β-actin mRNA. The results are expressed as the 
fold difference above the baseline quantity of normalized IκBα mRNA 
from siNT-transfected cells (set arbitrarily to 1; n = 3). (G) Cells trans-
fected as in Fig. 6 A were stimulated with TNFα for 45 min (left). Lungs 
were obtained from mice 8 or 24 h after OVA challenge (right). Cell or 
lung lysates were Western blotted with an anti–phospho-p65 (Ser 276) 
antibody, followed by reprobing with anti-p65 antibody (n = 3). Error 
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nucleus. Therefore, there is a considerable elevation of IκBα 
mRNA at early time points after TNFα stimulation.
Increased phosphorylation of p65 at Ser 276 in MK2- 
and HSP27-defi  cient cells
Phosphorylation of p65 enhances its ability to recruit histone 
acetylases to NF-κB–driven promoter sites, and thereby en-
hances transcription (33). Phosphorylation of  Ser276 is important 
for NF-κB–driven gene transcription in TNFα-stimulated 
cells (34). Western blotting demonstrated a signifi  cant increase 
in Ser276 phosphorylation in MK2- and HSP27-defi  cent 
HUVECs 45 min after TNFα stimulation (Fig. 7 G, left). 
Phosphorylation of Ser276 was also transiently increased in 
the lungs of MK2 KO mice shortly after OVA challenge (Fig. 
7 G, right).
Essential role of MSK1 in nuclear export of p65
We studied the kinases that are responsible for increased 
p65 phosphorylation. Ser276 is known to be targeted by two 
kinases: cytoplasmic PKAcα and nuclear MSK1 (35, 36). 
Figure 8.  The effect of MK2 on MSK1-driven nuclear export 
of p65. (A) HUVECs were cotransfected with siRNA against PKAcα 
(siPKAcα) and MK2 (siMK2; left) or MSK1 (siMSK1) and siMK2 (right). As 
a control, cells were cotransfected with siMK2 and nontargeting siRNA 
(siNT) or 2× siNT. Cell lysates were Western blotted with anti-PKAcα (top 
left) or anti-MSK1 (top right) antibodies. Membranes were reprobed se-
quentially with anti-MK2 antibody (middle) and with anti–β-tubulin 
antibodies (bottom; n = 3). (B) Cells cotransfected as in A were stimu-
lated with TNFα for 45 min. Lysates were Western blotted with an anti–
phospho-p65 (Ser 276) antibody (Ab), followed by sequential reprobing 
with an anti-IκBα and an anti-p65 antibodies. (C) Cells cotransfected as 
in A were stimulated with TNFα for 5 h and immunostained for p65 as 
in Fig. 6 B. The p65 N:C ratio was measured as in Fig. 6 D (n = 20–50 
representative cells from 3 separate experiments). (D and E) HUVECs 
transfected with siRNA for MK2 or nontargeting siRNA (siNT) were 
preincubated with SB 202190 (SB 202190 +) or vehicle DMSO (SB 
202190 −) and stimulated with TNFα for 30 min (TNFα +). Control cells 
were incubated with the vehicle without subsequent TNFα stimulation 
(TNFα −). (D) Cell lysates were Western blotted with an anti−phospho-
MSK1 (Thr581) antibody and reprobed with an anti-MSK1 antibody. 
(E) Cells were stained with an anti−phospho-MSK1 (Thr581) antibody 
(green) and DAPI (blue). Bars, 25 μm. The histogram shows mean inte-
grated intensity of phospho-MSK1 staining per 50 μm2 nucleus (n = 
100–200 representative cells from 3 separate experiments). Error bars 
represent the SEM.JEM VOL. 204, July 9, 2007  1647
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HUVECs were cotransfected with two sets of siRNA; one 
targeting MK2 and one targeting PKAcα or MSK1 (Fig. 8 A). 
Cotransfection with MSK1 siRNA, but not PKAcα siRNA, 
inhibited p65 phosphorylation and brought the IκBα level 
to the control (nontargeting siRNA-transfected) cell level 
(Fig. 8 B). MSK1 knockdown, but not PKAcα knockdown, 
also reversed the shortened nuclear presence of p65 NF-κB 
(Fig. 8 C). Next, the impact of MK2 on MSK1 activation was 
examined (Fig. 8, D and E). Western blotting and immuno-
staining with an anti–phospho-MSK1 (Thr581, activated form; 
[37]) revealed a pronounced increase in MSK1 activation in 
MK2-defi  cient HUVECs.
Figure 9.  The effect of MK2 and HSP27 on nuclear localization of 
p38. (A) HUVECs transfected as in Fig. 6 A were stimulated with TNFα 
for 30 min (+) or left unstimulated (−). Cells were immunostained for 
p38 (green). Bars, 25 μm. The integrated intensity of cytoplasmic and 
nuclear p38 staining was measured. The histogram shows the N:C ratio 
of p38 staining (n = 30–50 representative cells from 3 separate exper-
iments). (B) Lungs from immunized and challenged mice as in Fig. 1 A 
(left) or HUVECs transfected as in Fig. 6 A (right) were lysed, Western 
blotted with an anti-p38 antibody, and reprobed with an anti–β-tubulin 
antibody. (C, top) HUVECs were stimulated with TNFα for 5, 15, or 
30 min or left unstimulated. Cells were lysed and immunoprecipitated 
with a rabbit anti–phospho-HSP27 (Ser15) antibody. An additional 
sample of stimulated cell lysate was immunoprecipitated with a con-
trol rabbit IgG (cIgG). Immunoprecipitates were Western blotted with 
anti–phospho-p38 (Tyr182), followed by reprobing with an anti–phospho-
HSP27 (Ser15) antibody (n = 3). IgH, immunoglobulin heavy chain. 
(middle) An aliquot of a HUVEC lysate was depleted of phospho-HSP27 
by two cycles of immunoprecipitation. The post-pHSP27 immuno-
precipitation supernatant (pHSP27-depleted lysate) and another 
aliquot of the HUVEC lysate (nondepleted lysate) were then immuno-
precipitated with an anti-HSP27 antibody. An isotype-specifi  c mouse 
IgG (cIgG) was used as a control. Immunoprecipitates were Western 
blotted with an anti-p38 antibody, followed by reprobing with an anti-
HSP27 antibody (n = 2). (bottom) An aliquot of a pHSP27-depleted 
lysate and a nondepleted HUVEC lysate were Western blotted with an 
anti–phospho-HSP27 (Ser15) antibody. The membrane was reprobed 
with an anti–β-tubulin antibody (n = 2). (D) HUVECs were stimulated 
with TNFα for 5, 15, and 30 min, immunostained for phospho-p38 
(pTyr182, green) and HSP27 (red), and treated with DAPI (blue). Pic-
tures show the cell after 15 min of stimulation (n = 2). Bar, 10 μm. 
Similar cytosolic colocalization of phospho-p38 and HSP27 was also 
seen after 5 and 30 min of stimulation (not depicted). (E) HUVECs were 
transfected as in Fig. 6 A, preincubated with SB 202190 (+) or vehicle 
(−), and stimulated with TNFα for 5 h. p65 immunostaining and N:C 
ratio measurement were performed as in Fig. 6, B and D, respectively 
(n = 10–20 representative cells from 3 experiments). Error bars repre-
sent the SEM.1648  MK2, NF-κB, AND AIRWAY INFLAMMATION | Gorska et al.
Nuclear retention of p38 in MK2-defi  cient cells 
and reversal of shortened p65 nuclear presence 
by a p38 inhibitor
We examined the mechanism of increased MSK1 activation in 
MK2-defi  cient cells. p38 is known to activate MSK1 (38). Pre-
treatment of MK2 defi  cient HUVECs with the p38 inhibitor 
SB 202190 blocked TNFα-stimulated MSK1 phosphorylation 
(Fig. 8, D and E). MSK1 is found primarily in the nucleus (36). 
MK2 was reported to be essential for nuclear export of p38 upon 
cellular stress (39). This process required direct interaction be-
tween MK2 and p38. We investigated the cellular distribution of 
p38. Immunostaining showed that p38 redistributed from the 
nucleus to cytoplasm upon TNFα stimulation in control cells, 
as previously reported (39), but accumulated in the nucleus of 
MK2- and HSP27-defi  cient cells (Fig. 9 A). We believe that re-
tention of p38 in the nucleus in the absence of MK2 leads to 
phosphorylation and activation of its nuclear substrate MSK1. 
MK2 was reported to regulate the level of p38 protein (40). We 
detected a minor decrease in p38 level in the lungs of MK2 KO 
mice (Fig. 9 B). The expression of p38 was not decreased in 
MK2- or HSP27-defi  cient HUVECs. Our results are in agree-
ment with the previously cited paper (40), which showed that 
the regulation of p38 level by MK2 is cell specifi  c. Next, we 
addressed the mechanism of nuclear accumulation of p38 in 
HSP27-defi  cient cells. Phospho-HSP27 (Ser15) coprecipitated 
with phospho-p38 in TNFα-stimulated cells (Fig. 9 C, top). 
HSP27 lacking phosphorylation at Ser15 did not interact with 
p38 (Fig. 9 C, middle and bottom). Phospho-p38 and HSP27 
strongly colocalized in the cytoplasm, but not in the nucleus, in 
the course of TNFα stimulation (5, 15, and 30 min). Colocaliza-
tion at the 15-min time point is shown in Fig. 9 D. The results 
suggest that phospho-HSP27 binds to cytoplasmic phospho-p38 
and blocks its translocation to the nucleus. Next, we studied the 
role of p38 in nuclear retention of p65. Inhibition of p38 with 
SB 202190 reversed the shortened nuclear presence of NF-κB 
in MK2- and HSP27- defi  cient cells (Fig. 9 E).
Decreased stress fi  ber formation reduced VCAM-1, 
but not ICAM-1, expression as a consequence of MK2 
or HSP27 defi  ciency
We studied if the MK2–HSP27 pathway directly controlled 
endothelial cell function. MK2- and HSP27-defi  cient cells 
showed 2.9- and 3.7-fold reduction in actin polymerization, 
respectively (P < 0.05 for both cell types; Fig. 10 A). HSP27-
defi  cient cells demonstrated almost complete inhibition of 
TNFα-stimulated VCAM-1 expression (Fig. 10 B, top graph; 
P = 5.5 × 10−4). ICAM-1 expression was not aff  ected by 
HSP27 defi  ciency (Fig. 10 B, bottom graph).
Temporal control of NF-κB–induced transcript levels 
by MK2
We examined if the expression of other NF-κB–inducible 
genes was directly controlled by the MK2 pathway (Fig. 10 C). 
NF-κB–inducible genes can be classifi  ed into two groups: 
early-phase genes (e.g., IL-6 and Rel) and sustained-phase 
genes (early and late; e.g., E selectin and MCP-1). We have 
already shown that the expression of the early-phase target 
IκBα and the sustained-phase target VCAM-1 is increased 
and decreased, respectively, in MK2 KO mice. In agreement, 
MK2-defi  cient HUVECs showed a substantial increase in IL-6 
and Rel transcripts, but a marked decrease in E selectin and 
MCP-1 transcripts. The decrease in E-selectin and MCP-1 is 
likely to be important because both contribute to leukocyte 
extravasation and infl  ammation.
Reduced adhesion and transendothelial migration 
of mononuclear cells (MNCs) through a HSP27-defi  cient 
HUVEC monolayer
We studied adhesion and transendothelial migration of normal 
peripheral blood MNCs through TNFα-activated, HSP27-
defi  cient HUVECs. The percentage of MNCs that adhered 
to HSP27-suffi   cient and -defi  cient cells was 35.3 ± 0.3% 
and 18.5 ± 0.6%, respectively (P = 7.9 × 10−6; Fig. 10 D, 
left graph). MNC migration under the gradient of MCP-1 
through the HSP27-defi  cient cell monolayer was severely 
  reduced (P = 0.0036) compared with migration through 
control cell monolayer (Fig. 10 D, right graph). We believe 
that the impaired actin polymerization and adhesion molecule 
expression caused by HSP27 defi  ciency results in the failure 
of MNCs to adhere to and migrate through the endothelial 
cell monolayer.
D  I  S  C  U  S  S  I  O  N 
We have identifi  ed MK2–HSP27 as a critical signaling path-
way regulating endothelial barrier and infl  ammation. MK2 
KO mice are unable to mount an airway allergic infl  amma-
tion. MK2 defi  ciency does not impair systemic Th2 response, 
but results in reduced endothelial permeability. The decreased 
permeability correlates with the impaired actin polymeriza-
tion and lack of adherens junction disruption. In the absence 
of MK2, the expression of critical adhesion molecules and 
chemokines is impaired. Thus, MK2 regulates the develop-
ment of the local (lung) infl  ammation primarily by control-
ling endothelium.
MK2 seems to regulate select genes, cells, and organs. 
OVA-sensitized MK2 KO mice demonstrate decreased ex-
pression of Th2 cytokines in the lung, but normal production 
of innate, Th1, and Th2 cytokines in the liver. It has been pre-
viously shown that MK2 KO mice clear Listeria monocytogenes 
from the liver and blood, but not from the lung (41). MK2 KO 
mice have a defect in the synthesis of TNF-α and IFN-γ. The 
production of ΙL-1 and -6 is decreased in spleen cells (9), but 
not in bone marrow–derived macrophages (41). The results 
suggest a heterogeneous response that is perhaps caused by dif-
ferent disease models that have been examined. The hetero-
geneous response also likely results from the variable expression 
pattern of MK2 and HSP27 in diff  erent organs and cells.
VCAM-1, but not ICAM-1, expression is regulated by the 
p38 pathway (6). NF-κB is a major transcription factor for 
VCAM-1 (20). MK2 is essential for sustained nuclear pres-
ence of NF-κB (Fig. 10 E). MK2 prevents premature export 
of NF-κB from the nucleus by decreasing the NF-κB–driven JEM VOL. 204, July 9, 2007  1649
ARTICLE
Figure 10.  Direct effect of MK2 and HSP27 on endothelial cell 
function. (A) HUVECs were transfected as in Fig. 6 A, stimulated with 
TNFα for 30 min and stained with rhodamine-labeled phalloidin to detect 
polymerized actin (red). Bars, 50 μm. The histogram shows mean pixel 
intensity of staining per cell (n = 20–30 representative cells from 3 ex-
periments). Staining intensity is expressed in AU. (B) HUVECs transfected 
with siHSP27 and siNT as in Fig. 6 A were assayed for VCAM-1 (top histo-
gram) or ICAM-1 (bottom histogram) expression by ELISA. Histograms 
show mean optical density at 450 nm as a measure of VCAM-1 (left) or 
ICAM-1 (right) expression per well (each experiment in triplicates, n = 3). 
(C) Kinetics of NF-κB target gene mRNA expression in MK2-defi  cient 
HUVECs after TNFα stimulation was assessed. Cells transfected with 
siMK2 or siNT as in Fig. 6 A were stimulated as in Fig. 7 E. mRNA for IL-6, 
Rel, E selectin, MCP-1, and β-actin was measured by real-time RT-PCR. 
The quantity of IL-6, Rel, E-selectin, and MCP-1 mRNA was normalized to 
the quantity of β-actin mRNA. Results are expressed as fold difference 
above the baseline quantity of normalized mRNA from siNT-transfected 
cells (set arbitrarily to 1; n = 3). (D) HUVECs were transfected as in 
Fig. 10 B. The adhesion of human peripheral blood MNCs to transfected 
TNFα-treated HUVECs and the migration of MNCs through the trans-
fected and TNFα-treated HUVEC monolayer in transwells were measured. 
The mean percentage of MNCs that adhered to (left) or migrated (right) 
through the HUVEC layer is shown (each experiment in triplicates; n = 3). 
(E) A proposed model of NF-κB regulation by MK2. (left) Spatial regula-
tion of NF-κB by the MK2 pathway. Phospho-HSP27 binds p38 in the 
cytoplasm and prevents its translocation to the nucleus. MK2 facilitates 
export of p38 from the nucleus. By reducing the level of p38 in the nu-
cleus, MK2 and HSP27 decrease the phosphorylation of nuclear MSK1. 
This results in reduced p65 phosphorylation and IκBα expression. Newly 
synthesized IκBα mediates nuclear export of p65 and functions as a neg-
ative feedback for the NF-κB pathway. By regulating p38 and MSK1, the 
MK2 pathway controls the level of the negative feedback in the NF-κB 
pathway (black arrow, translocation; colored arrow, enzymatic or trans-
criptional effect). (right) Temporal regulation of NF-κB signal strength 
by the MK2 pathway. In the presence of MK2 in normal cells (MK2+), the 
initial burst of NF-κB causes a modest increase in IκBα synthesis, which 
results in a tempered export of NF-κB and its prolonged transcriptional 
activity. In the absence of MK2 (MK2−, pink zone), the NF-κB signal 
strength overshoots in the early phase because of enhanced p65 phos-
phorylation. This causes an overzealous IκBα response, leading to pre-
mature export of NF-κB. As a result, the late-phase transcriptional activity 
of NF-κB is lost. MK2 switches the pattern of NF-κB activation from 
elevated, but short lasting, to moderate-level, but prolonged. Error bars 
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transcription of its exporter IκBα. MK2 reduces the level of 
p65 NF-κB phosphorylation. The latter occurs through the 
sequential action of p38 and MSK1. Under normal circum-
stances, MK2 facilitates export of p38 from the nucleus (39), 
and thereby adjusts the magnitude of negative feedback in the 
NF-κB pathway. MK2 decreases the amplitude of the early-
phase NF-κB signal and converts it into a sustained phase signal. 
Thus, we provide a novel mechanism for a regulatory cross-
talk between the p38 and NF-κB pathways through MK2 
and MSK1. We also uncovered a mechanism for cytoplasmic 
retention of p38 through the physical interaction with phospho-
HSP27. The subcellular distribution of p38 is regulated by its 
two downstream molecules. MK2 exports p38 from the nucleus 
and HSP27 retains it in the cytosol.
Previously, Park et al. linked the p38 MAPK–MSK1/2 
pathway to a subset of NF-κB target genes in macrophages 
through two diff  erent mechanisms—one through the phos-
phorylation of CREB (Ser133) and the other through chroma-
tin modifi  cation (42). In our study, the phosphorylation of 
CREB (Ser133) was unchanged in MK2 KO mice compared 
with control mice. Thus, CREB is unlikely to explain the pheno-
type of the MK2 KO mice. We did not examine the eff  ect of 
the MK2 knockout on chromatin modifi  cation of NF-κB tar-
get genes. Thus, it is possible that additional mechanisms con-
tribute to the phenotype that was observed in MK2 KO mice. 
In summary, we have identifi  ed a critical role for MK2 and 
HSP27 in endothelial cell signaling. MK2 and HSP27 regulate 
aspects of endothelial function that are essential for their perme-
ability and adhesiveness to infl  ammatory cells. Inability to regu-
late this endothelial function leads to an aborted local immune 
response in the face of a normal systemic immune response. 
Thus, MK2 and HSP27 represent attractive targets for therapeu-
tic intervention in asthma and other infl  ammatory diseases.
MATERIALS AND METHODS
Mice. MK2 knockout C57BL/6J mice were generated in Dr. Matthias 
Gaestel’s laboratory (9). All procedures on mice were approved by the 
  University of Texas Medical Branch and the National Jewish Medical and 
Research Center Institutional Animal Care and Use Committees and per-
formed according to committee guidelines.
Immunization, inhalation challenge, BAL, and endothelial permea-
bility.  OVA sensitization, inhalation challenge, and BAL of mice were done 
as previously described (10). The intranasal administration of LPS or saline 
(control) was done as previously described (43). Mice were killed 8 h after 
LPS or saline administration. Lung vascular permeability was measured as 
previously described (11).
Measurement of AHR.  Anesthetized mice were connected to a ventilator 
(FlexiVent; SCIREQ) via a tracheal 18-gauge cannula and ventilated under 
constant fl   ow conditions limited to 30 cm H2O at a frequency of 150 
breaths/min with a tidal volume of 8 ml/kg, while breathing against an arti-
fi  cial positive end-expiratory pressure of 2.5 cm H2O. Before the measure-
ments were taken, lungs were infl  ated four times to total lung capacity. For 
resistance measurements, a single-frequency (2.5-Hz) sinusoidal piston vol-
ume movement with a peak tidal volume of 0.15 ml was applied. Pressure, 
volume, and fl  ow data were fi  t to the linear single compartment model to 
obtain values for total lung resistance. A baseline lung resistance (no aerosol 
administration), lung resistance in response to saline alone, and lung resis-
tance to increasing doses of methacholine (6.25–50 mg/ml in saline) aerosol 
were sequentially obtained. Airway resistance was measured several times at 
each methacholine dose, and three peak resistance values (coherence >90%) 
were taken into account.
Adoptive transfer of OT-2 T cells.  Adoptive transfer of activated OT-2 
T cells to MK2 KO and control mice and the exposure of transferred ani-
mals to OVA aerosol were performed according to the previously described 
protocol (16).
Histology, immunofl  uorescent staining, and phalloidin staining of 
fi  lamentous actin. Hematoxylin and eosin (HE), periodic acid-Schiff   (PAS), 
and Trichrome staining of lung sections was done at the University of Texas 
Medical Branch or National Jewish Medical and Research Center Histology 
Core Laboratories according to the standard protocol. Immunofl  uorescent 
staining of lung sections and paraformaldehyde-fi  xed HUVECs were performed 
as previously described (44). For actin staining, samples were permeabilized 
with 0.05% saponin in PBS for 15 min and incubated with rhodamine-
labeled phalloidin (Sigma-Aldrich) at 0.2 μg/ml for 30 min
ELISA to measure the DNA-binding capacity of NF-𝗋B p65. The 
ability of NF-κB p65 from the nuclear extract to bind the DNA consensus 
sequence was assessed using an ELISA-based TransAM NF-κB p65 kit (Active 
Motif, Inc.) according to the manufacturer’s protocol.
Real-time PCR. RNA  purifi  ed from Trizol (Invitrogen) lysates was reverse 
transcribed using Superscript III (Invitrogen) according to the manufacturer 
protocol. SYBR Green PCR Master Mix (Applied Biosystems) was used for 
DNA amplifi  cation. Primer sequences are shown in the Supplemental materi-
als and methods (available at http://www.jem.org/cgi/content/full/jem
.20062621/DC1). Real-time PCR was performed with the ABI Prism 7000 
Sequence Detection System (Applied Biosystems).
OVA-specifi  c IgE, cytokine production, and splenocyte prolifera-
tion. The ELISA for OVA-specifi  c IgE was performed as previously de-
scribed (10). IL-4, IL-5, IFNγ, and TNFα in liver lysates was quantifi  ed by 
ELISA according to the manufacturer’s protocol (OptEIA sets; BD Bio-
sciences) and adjusted for the protein concentration. Thymidine incorporation 
assay was performed as previously described (45).
Chemotaxis assays. CD4 T cell chemotaxis to 10−7 M MCP-1 was per-
formed as previously described (46). CD4 T cells were isolated from the 
splenocyte suspension by negative selection using a CD4 T Cell Isolation kit 
(Miltenyi Biotec). The transendothelial migration assay was performed as 
previously described (47). Peripheral blood MNC migration through the 
TNFα-stimulated HUVEC monolayer was induced by MCP-1 at 10−7 M.
HUVEC culture and stimulation.  HUVECs (Clonetics; passage 1–4) were 
cultured in EGM-2 media (Clonetics) as recommended by the manufacturer. 
For Western blotting, real-time PCR and immunofl  uorescent staining experi-
ment HUVECs were stimulated with TNFα at 10 ng/ml. When indicated, 
cycloheximide, leptomycin B, or SB 202190 was added 30 min before TNFα 
stimulation at 25 μg/ml, 20 nM, and 1 μg/ml, respectively.
Transfection of HUVECs with siRNA or plasmids. siRNA  oligonu-
cleotide sequence for human HSP27 and human MK2 were previously de-
scribed (22, 48). siRNA for PKAcα and for MSK1 were obtained from the 
predesigned siGenome collection from Dharmacon. As a negative control, 
siRNA against fi  refl   y luciferase (siControl Non-Targeting siRNA # 2; 
Dharmacon) was used. HA-tagged human HSP27 WT and HSP27 Ser78, 
82Ala mutant in pcDNA3 expression vector were a gift from M. Gaestel 
(Hannover Medical School, Hannover, Germany). Mutation of Ser15 to Ala 
(AGC to GCC) in HSP27 Ser78, 82Ala cDNA-containing vector was per-
formed using the QuikChange (Stratagene) site-directed mutagenesis proto-
col, as previously described (45). HUVEC transfection was performed as 
previously described (49).JEM VOL. 204, July 9, 2007  1651
ARTICLE
HUVEC lysis, immunoprecipitation, electrophoresis, and Western 
blotting. Preparation of HUVEC lysate in the modifi  ed RIPA buff  er, 
immunoprecipitation, and Western blotting were performed as previously 
described (45).
VCAM-1 and ICAM-1 ELISA and adhesion assay with HUVECs. 
VCAM-1 and ICAM-1 expression on HUVECs was measured by ELISA, as 
previously described (50). For the adhesion assay, CMTMR-labeled MNCs 
(2 × 105) were added to washed HUVEC monolayers and incubated at 
37°C in 5% CO2 for 1 h. After washing, adherent cells were recovered by 
trypsinization and CMTMR-positive cells were counted.
Morphometric and statistical analysis. For quantifi  cation of fl  uores-
cence and light microscopic results, data from 2–10 fi  elds per lung section 
obtained from 3–8 mice per group were analyzed. For morphometric ana-
lyses, we studied mid-size bronchi of the epithelial basement membrane 
(BM) perimeter in the range of 0.4–2.0 mm (51–53). The results are ex-
pressed as a staining-positive area or the number of staining-positive (e.g., 
PAS) cells per unit (1 mm) of the BM perimeter. To measure infl  ammation 
(HE staining) or ECM deposition (Trichrome staining), the areas of peri-
bronchial cellular infi  ltrate or peribronchial areas positive for blue color, 
respectively, were traced and circled using the region selection tool of the 
morphometric software (MetaMorph; Invitrogen) as previously described 
(54, 55). Individual areas of infl  ammation or ECM deposition around a single 
bronchus were added and the area sum was divided by the BM perimeter. 
To assess mucus production, the number of purple stain–positive cells (PAS 
staining) in the epithelium of mid-size bronchi was counted as previously 
described (55). For blood vessel studies, we examined small to mid-size 
blood vessels of 0.1–1.5-mm lumen perimeter. The fl  uorescent microscopy 
image analysis was as follows. Integrated pixel intensity was defi  ned as a sum 
of fl  uorescent intensities of all pixels in the measured area. Mean pixel inten-
sity was defi  ned as integrated intensity divided by the measured area. The 
same exposure time was used to capture images in all experimental groups in 
a particular set of experiments. Fluorescent staining-positive areas were de-
fi  ned using the intensity threshold command. The same threshold was ap-
plied to all images from a particular set of experiments. Statistical analysis was 
done by two-tailed Student’s t test. Results are shown as the mean ± the 
SEM. P < 0.05 was considered statistically signifi  cant.
Online supplemental material. Fig. S1 shows images of polymerized 
actin in the pulmonary endothelium from MK2 KO and control mice at 
diff  erent time points after OVA challenge. Fig. S2 shows airway remodel-
ing (PAS, Trichrome staining, and immunostaining for smooth muscle actin) 
of MK2 KO and control mice. Supplemental material and methods contain 
the list of antibodies and sequences of real-time PCR primers. The online 
version of this article is available at http://www.jem.org/cgi/content/full/
jem.20062621/DC1.
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